JT

John F. Traverse

BS Bristol-Myers Squibb: 23 patents #194 of 3,969Top 5%
SP Signal Pharmaceuticals: 3 patents #109 of 207Top 55%
Merck: 1 patents #5,419 of 9,382Top 60%
📍 Lebanon, NJ: #10 of 221 inventorsTop 5%
🗺 New Jersey: #2,630 of 69,400 inventorsTop 4%
Overall (All Time): #141,303 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDate
12343346 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2025-07-01
12227519 Preparation of maytansinol Nareshkumar Jain, Srinath Thirumalairajan, Sanjeevani Ghone 2025-02-18
11912644 Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate Michael J. Zacuto, Weihong Zhang, Kirsten Faye Johnson, Maryll E. Geherty, Christopher Marton 2024-02-27
11655257 MK2 inhibitors, synthesis thereof, and intermediates thereto Gregg Feigelson, Maryll E. Geherty, Richard M. Heid, Jr., Mohit Atul Kothare, Hon-Wah Man +3 more 2023-05-23
11566004 Process for the preparation of bromodomain inhibitor Kelvin Hin-Yeong Yong, Antonio Christian Ferretti, Hekla Alite, Jonathan Moseley, Antonio Maria Ruda +2 more 2023-01-31
11505522 Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate Michael J. Zacuto, Weihong Zhang, Kirsten Faye Johnson, Maryll E. Geherty, Christopher Marton 2022-11-22
11241439 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2022-02-08
11014940 Thiazolidinone and oxazolidinone compounds and formulations Sanjeevani Ghone, Fu-An Kang, Francisco Velazquez 2021-05-25
10894796 MK2 inhibitors, synthesis thereof, and intermediates thereto Gregg Feigelson, Maryll E. Geherty, Richard M. Heid, Jr., Mohit Atul Kothare, Hon-Wah Man +3 more 2021-01-19
10717703 Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate Michael J. Zacuto, Weihong Zhang, Kirsten Faye Johnson, Maryll E. Geherty, Christopher Marton 2020-07-21
10646503 Isotopologues of 5-azacytidine William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom 2020-05-12
10596180 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2020-03-24
10463672 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2019-11-05
10463683 Isotopologues of 5-azacytidine William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom 2019-11-05
10220050 Isotopologues of 5-azacytidine William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom 2019-03-05
9974786 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use Marie Georges Beauchamps, Antonio Christian Ferretti, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke +3 more 2018-05-22
9975872 Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof Chengmin Zhang, Gregg Feigelson, Benjamin M. Cohen, William W. Leong 2018-05-22
9969712 Process for the preparation of isotopologues of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof 2018-05-15
9884062 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2018-02-06
9795603 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Marie Georges Beauchamps, Antonio Christian Ferretti, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke +3 more 2017-10-24
9695145 Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof 2017-07-04
9629849 Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2017-04-25
9604939 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Marie Georges Beauchamps, Antonio Christian Ferretti, Juan Antonio Gamboa, Kevin J. Klopfer, William Edward Konnecke +3 more 2017-03-28
9309220 Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof Chengmin Zhang, Gregg Feigelson, Benjamin M. Cohen, William W. Leong 2016-04-12
9221788 Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same Benjamin M. Cohen, Jean Xu, Ying Li 2015-12-29